Takeda to buy inflammatory disease drug for $4 billion from Nimbus

Fargo, ND, USA / The Mighty 790 KFGO | KFGO

Dec 13, 2022 | 6:37 AM

(Reuters) – Takeda Pharmaceutical said on Tuesday it would acquire Nimbus Therapeutics’ experimental inflammatory disease treatment for $4 billion in upfront payment.

(Reporting by Khushi Mandowara; Editing by Vinay Dwivedi)

Political influencer charged with bias crime after knocking down ice sculpture at MN capitol

4h ago

Body of missing Rochester man located in northeast Iowa

4h ago

Gov. Tim Walz to release 'Good Neighbors,' inspired by ICE surge and the pushback

48m ago

Ag colleagues share condolences on the passing of Congressman David Scott

4h ago

ACE welcomes farm bill amendment to make nationwide, year-round E15 permanent

2h ago

New CDC director will be allowed to make her own decisions, Kennedy tells US Senate panel

3h ago

Takeda to buy inflammatory disease drug for $4 billion from Nimbus

Current Weather »

Fargo, ND